Target intelligence / Profile preview

Amyloid beta precursor protein binding family B member 3 (APBB3)

Target
APBB3
Molecular classification
Other (adaptor/scaffold protein)
01

Overview

Amyloid beta precursor protein binding family B member 3 (APBB3), also called Fe65L2, is an intracellular adaptor protein primarily localized to the cytoplasm and sometimes the nucleus[1][3][5][7]. It is a member of the APBB protein family, which is characterized by WW and phosphotyrosine‐binding (PTB) domains[1]. APBB3 binds to the intracellular domain of the amyloid precursor protein (APP) as well as APP-like proteins, influencing APP signaling, internalization, and processing—a central pathway implicated in Alzheimer's disease pathogenesis[1][3][5][7]. Alternative splicing of APBB3 produces multiple isoforms with varying binding and localization properties[1]. Additionally, APBB3 has candidate roles in synaptic development and neurodevelopmental processes. Although associated with disease pathways (notably neurodegeneration), it is not an established therapeutic target[1][3][5].

Other names
Amyloid-beta A4 precursor protein-binding family B member 3Fe65L2Protein Fe65-like 2SRAFE65-like protein 2Amyloid precursor interacting proteinAPBB3_HUMAN
02

Mechanism of action

Not applicable; not an established drug target

03

Biological functions

Regulation of amyloid precursor protein (APP) processingScaffold/adaptor in protein complexesModulation of protein internalizationSynaptic plasticityNeurodevelopment
04

Disease associations

Neurodegenerative disease (particularly Alzheimer's disease)Cancer (reported association with cervical cancer)

Beyond the preview

Go deeper on Amyloid beta precursor protein binding family B member 3 (APBB3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Amyloid beta precursor protein binding family B member 3 (APBB3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call